Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up

Congenital dyserythropoietic anemia type 2

MONDO:0009134

Congenital dyserythropoietic anemia type II (CDA II) is the most common form of CDA characterized by anemia, jaundice and splenomegaly and often leading to liver iron overload and gallstones.

Also known as: CDA II, CDA type 2, CDA type II, SEC23B-CDG, congenital dyserythropoietic anemia type 2, dyserythropoietic anemia, congenital, type II, hereditary erythroblastic multinuclearity with a positive acidified-serum test (hempas), CDAN2

8 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Disease (680) Anemia (233) Metabolic disease (233) Hereditary disease (176) Hematologic disorder (170) Inborn errors of metabolism (45) Hemolytic anemia (19) Human disease (14) Congenital disorder of glycosylation (7) Congenital dyserythropoietic anemia (4)
Trials to join now! 3 Not yet recruiting 2 Not yet finished but already full! 1 Completed 2
Sort by
  • New blood treatment could block zika in transfusions

    Disease control Ongoing

    This study tests a special treatment for red blood cells that aims to kill the Zika virus, making transfusions safer. About 692 people who need blood transfusions will receive either treated or standard blood. The goal is to see if the treated blood works just as well and is safe…

    Phase: PHASE3 • Sponsor: Cerus Corporation • Aim: Disease control

    Last updated Jun 27, 2026 11:03 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space